In an effort to understand the dysregulation of NK cells in AML patients, we found that glycogen synthase kinase beta (GSK3-β) protein levels are upregulated in NK cells from AML patients as compared with normal donors. The gene discussed is GSK3B; the disease is acute myeloid leukemia.